By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

OncoMed Pharmaceuticals, Inc. 

800 Chesapeake Drive

Redwood City  California  94063  U.S.A.
Phone: 650-995-8200 Fax: 650-298-8600


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





Company News
OncoMed Pharmaceuticals, Inc. (OMED) Begins Patient Dosing In Phase 2 Clinical Trial of Tarextumab (Anti-Notch 2/3, OMP-59R5) in Small Cell Lung Cancer 12/1/2014 9:46:30 AM
OncoMed Pharmaceuticals, Inc. (OMED) Presents New Clinical And Biomarker Data From Its Tarextumab And Demcizumab Clinical Trials At The European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Symposium 11/24/2014 12:55:50 PM
OncoMed Pharmaceuticals, Inc. (OMED) To Present At Piper Jaffray Healthcare Conference 11/21/2014 10:01:04 AM
OncoMed Pharmaceuticals, Inc. (OMED) Presents Biomarker-Focused Clinical Data From Phase 1a Trial Of Anti-Notch1 (OMP-52M51) In Oral Plenary Session At The 26th OncoMed Pharmaceuticals, Inc. (OMED)-European Organization for Research and Treatment of Cancer-National Cancer Institute Symposium 11/19/2014 9:35:09 AM
OncoMed Pharmaceuticals, Inc. (OMED) Announces Third Quarter 2014 Financial And Operating Results 11/5/2014 7:44:50 AM
OncoMed Pharmaceuticals, Inc. (OMED) Granted Anti-DLL4/Anti-VEGF Bispecific Antibody Patent In The U.S. 11/3/2014 7:50:40 AM
OncoMed Pharmaceuticals, Inc. (OMED) To Present Clinical And Preclinical Data At The 26th European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Symposium On Molecular Targets And Cancer Therapeutics Meeting 10/30/2014 10:54:41 AM
OncoMed Pharmaceuticals, Inc. (OMED) To Announce Financial Results For The Third Quarter 2014 On Tuesday, November 4, 2014, After Close Of U.S.-Based Financial Markets 10/29/2014 7:55:03 AM
OncoMed Pharmaceuticals, Inc. (OMED) To Present At The 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 10/7/2014 7:53:52 AM
OncoMed Pharmaceuticals, Inc. (OMED) Announces Selection Of First Small Molecule Product Candidate Targeting The Wnt Pathway Under Collaboration With Bayer Pharma AG 9/30/2014 7:57:24 AM
12345678910...
//-->